A 2026 meta-analysis of 28 studies found that microbiome-targeted interventions, including probiotics and special diets, produced small reductions in children’s body weight and inflammation markers compared to placebo. According to Gram Research analysis, body mass index z-score decreased by 0.36 points and C-reactive protein (an inflammation marker) decreased by 0.68 points. However, these treatments did not significantly improve cholesterol, blood sugar control, or blood pressure, suggesting they may help with early weight and inflammation management but are not a complete solution for preventing heart disease in children.
A Gram Research analysis of 28 studies found that treatments targeting children’s gut bacteria, such as probiotics and special diets, produced small improvements in body weight, liver health, and immune system markers. However, the research showed no clear benefits for cholesterol, blood sugar control, or blood pressure. While these gut-focused interventions show promise for early prevention of heart disease and obesity in kids, scientists say longer studies are needed to determine if the improvements are significant enough to make a real difference in children’s long-term health.
Key Statistics
A 2026 meta-analysis of 28 randomized controlled trials found that microbiome-targeted interventions reduced body mass index z-score by 0.36 points in children and adolescents compared to placebo.
According to research reviewed by Gram, microbiome-targeted interventions decreased C-reactive protein, a marker of inflammation, by 0.68 points in children, suggesting benefits for immune system health.
A systematic review and meta-analysis of 21 studies found no significant improvements in cholesterol levels, blood sugar control, or blood pressure following microbiome-targeted interventions in children and adolescents.
The 2026 meta-analysis showed a small overall reduction of 0.21 points across multiple cardiometabolic markers when combining all health measures affected by gut-bacteria interventions in children.
The Quick Take
- What they studied: Whether changing the bacteria in children’s guts through diet, probiotics, or other treatments could reduce their risk of developing heart disease, obesity, and related health problems.
- Who participated: Twenty-eight randomized controlled trials involving children and teenagers aged 1 month to 19 years. Participants were randomly assigned to either receive a gut-bacteria-targeting treatment or a placebo (fake treatment).
- Key finding: Microbiome-targeted interventions reduced body mass index z-score by 0.36 points and C-reactive protein (an inflammation marker) by 0.68 points compared to placebo, with small overall improvements across multiple cardiometabolic markers.
- What it means for you: Changing gut bacteria through diet or probiotics may help children maintain healthier weight and reduce inflammation, but current evidence does not support using these treatments to lower cholesterol or blood pressure. More research is needed before doctors can confidently recommend these interventions for disease prevention.
The Research Details
Researchers conducted a systematic review and meta-analysis, which means they searched multiple medical databases for all published studies testing gut-bacteria interventions in children. They found 28 studies that met their criteria. Twenty-one of these studies had enough data to combine statistically. The interventions tested included special diets designed to feed healthy bacteria, probiotics (supplements containing beneficial bacteria), prebiotics (foods that help good bacteria grow), synbiotics (a combination of probiotics and prebiotics), and fecal microbiome transfer (transplanting healthy bacteria from a donor into a child’s gut). The researchers measured outcomes including body weight, cholesterol levels, liver function, blood sugar control, blood pressure, and inflammation markers. They used a statistical method called inverse-variance weighted random-effects meta-analysis to combine results across studies while accounting for differences in study quality and design.
This research approach is important because individual studies on this topic are often small and produce mixed results. By combining data from multiple studies, researchers can identify patterns and get a clearer picture of whether these treatments actually work. The meta-analysis also allowed scientists to look at which outcomes improved most consistently, suggesting which health problems might benefit most from gut-bacteria interventions. This systematic approach helps doctors and parents make informed decisions about whether these treatments are worth trying.
This study was registered in advance (PROSPERO CRD42022321814), which reduces bias and increases credibility. The researchers searched six major medical databases, making it unlikely they missed important studies. However, the included studies varied in quality, participant age, intervention type, and duration, which can affect how reliable the combined results are. The researchers used statistical methods to account for these differences. The fact that only 21 of 28 studies had enough data to combine means some evidence was excluded, which could affect the overall conclusions.
What the Results Show
Compared to placebo, microbiome-targeted interventions produced a small but measurable reduction in body mass index z-score (a standardized measure of weight for age and height), with an effect size of 0.36 points. This means children receiving these treatments weighed slightly less than those receiving placebo. The interventions also reduced C-reactive protein, a marker of inflammation in the body, by 0.68 points. There was a borderline reduction in alanine aminotransferase, an enzyme that indicates liver health, suggesting these treatments may help protect the liver. When researchers combined all cardiometabolic markers together, they found a small overall improvement of 0.21 points. These improvements were consistent across studies, suggesting the effects are real rather than due to chance.
The research found no significant improvements in body fat percentage, cholesterol levels, insulin resistance (a precursor to diabetes), or blood pressure. These findings suggest that while gut-bacteria interventions may help with weight and inflammation, they do not appear to address all aspects of cardiometabolic health. The researchers noted that the improvements observed were strongest for early biological markers of disease (weight, liver function, and inflammation) rather than downstream risk factors like cholesterol and blood pressure. This pattern suggests these interventions may work best as early prevention tools rather than treatments for established disease.
Previous research in adults showed that microbiome-targeted interventions could improve various cardiometabolic outcomes, but this is one of the first comprehensive reviews examining whether similar benefits occur in children. The findings in children are more modest than in adults, suggesting that age may influence how much gut bacteria changes affect health. The lack of improvement in cholesterol and blood pressure in children contrasts with some adult studies, indicating that children’s bodies may respond differently to these interventions. This research fills an important gap by showing that benefits seen in adults do not automatically translate to children.
The included studies varied widely in design, participant age, intervention type, and duration, making it difficult to draw firm conclusions. Some studies were small and may not have had enough power to detect real effects. The researchers could only combine data from 21 of 28 studies, meaning some evidence was excluded. Most studies were relatively short, lasting weeks to months, so it is unclear whether benefits persist over years. The mechanisms by which gut bacteria changes affect cardiometabolic health in children remain poorly understood. Finally, publication bias may exist, meaning studies showing positive results are more likely to be published than those showing no effect.
The Bottom Line
Based on current evidence, microbiome-targeted interventions such as probiotics and dietary changes may offer modest benefits for weight management and inflammation reduction in children, with moderate confidence. However, these interventions should not be relied upon as primary treatments for high cholesterol or high blood pressure. Parents interested in these approaches should discuss them with their child’s doctor. For general health promotion, maintaining a balanced diet rich in fiber and whole foods remains the most evidence-based approach. More research is needed before these interventions can be confidently recommended for disease prevention in all children.
This research is most relevant to parents of children with obesity or early signs of metabolic problems, pediatricians and family doctors, public health officials developing prevention programs, and researchers studying childhood cardiometabolic disease. Children with established high cholesterol, high blood pressure, or diabetes should not rely solely on these interventions without medical supervision. Healthy children may benefit from general dietary improvements that support healthy gut bacteria, but targeted interventions are not yet proven necessary for prevention in this group.
Based on the studies reviewed, improvements in weight and inflammation markers appeared within weeks to months of starting interventions. However, most studies lasted less than six months, so it is unclear whether benefits persist over longer periods. Realistic expectations are modest improvements in weight and inflammation within 2 to 3 months, with the understanding that these changes are small and may not be noticeable in daily life. Long-term benefits for preventing heart disease and other cardiometabolic conditions remain unknown and require further research.
Frequently Asked Questions
Do probiotics actually help kids lose weight?
Research shows probiotics and other gut-bacteria interventions produce small reductions in body weight, with a body mass index z-score decrease of 0.36 points. However, these improvements are modest and should be combined with healthy diet and exercise for best results.
Can changing gut bacteria lower a child’s cholesterol?
Current evidence does not support using gut-bacteria interventions to lower cholesterol in children. A 2026 meta-analysis found no significant improvements in cholesterol levels following these treatments, though weight and inflammation markers did improve slightly.
What is the best way to improve a child’s gut bacteria?
Increasing dietary fiber through whole grains, fruits, and vegetables is the most evidence-based approach to support healthy gut bacteria. Probiotic supplements may offer modest additional benefits for weight and inflammation, but dietary changes should be the foundation.
How long does it take to see benefits from probiotics in children?
Studies reviewed showed improvements in weight and inflammation within weeks to months of starting interventions. However, most research lasted less than six months, so long-term benefits remain unclear. Expect modest changes rather than dramatic results.
Are microbiome interventions safe for children?
The reviewed studies did not report serious safety concerns, but most were short-term. Parents should discuss any probiotic supplements or dietary changes with their child’s doctor, especially if the child has a weakened immune system or other health conditions.
Want to Apply This Research?
- Track weekly body weight and waist circumference, along with dietary fiber intake (grams per day) and probiotic supplement use. Monitor subjective energy levels and digestive comfort on a 1-10 scale to capture changes not reflected in weight alone.
- Users can implement a practical dietary change by increasing fiber intake to 25-30 grams daily through whole grains, fruits, and vegetables, which feeds healthy gut bacteria. If considering probiotics, select a specific strain and log daily intake. Track adherence to these changes weekly to identify barriers and maintain motivation.
- Establish a baseline of current weight, dietary habits, and any available inflammation markers (such as C-reactive protein from a doctor’s test). Reassess these metrics every 4 to 8 weeks. If using the app with a healthcare provider, share data during regular check-ups to determine whether observed changes are meaningful and whether the intervention should continue.
This research summary is for educational purposes only and should not replace professional medical advice. Microbiome-targeted interventions show promise for modest improvements in weight and inflammation in children, but current evidence does not support using them as primary treatments for high cholesterol, high blood pressure, or diabetes. Parents considering probiotics, dietary changes, or other gut-bacteria interventions for their child should consult with a pediatrician or registered dietitian. This is especially important for children with existing health conditions, those taking medications, or those with compromised immune systems. The findings presented here reflect current research but may change as new evidence emerges.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.